Drugs / liposome-encapsulated doxorubicin citrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00911183 | Dec 2008 → Dec 2012 | lymphoma | Institut Bergonié | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liposome-encapsulated doxorubicin citrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00911183 ↗ |
| Route | Intravenous | “Given IV” NCT00911183 ↗ |